ReviewFrontiers in oncology2026

The NRF2 signaling pathway in hepatocellular carcinoma: dual roles, epigenetic reprogramming, and therapeutic opportunities in metabolic vulnerability.

Yue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.